WATSON 669 (Enalapril 5 mg)
Pill imprint WATSON 669 has been identified as Enalapril maleate 5 mg.
Enalapril is used in the treatment of high blood pressure; heart failure; diabetic kidney disease; hypertensive emergency; alport syndrome (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Enalapril 5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- WATSON 669
- Strength:
- 5 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-0669
- Inactive Ingredients:
- lactose anhydrous
crospovidone
magnesium stearate
microcrystalline cellulose
potassium bicarbonate
More about enalapril
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
